000 04417nam a22005655i 4500
001 978-3-031-54960-1
003 DE-He213
005 20251030112055.0
007 cr nn 008mamaa
008 240523s2024 sz | s |||| 0|eng d
020 _a9783031549601
_9978-3-031-54960-1
024 7 _a10.1007/978-3-031-54960-1
_2doi
050 4 _aRC666-701.2
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
072 7 _aMJD
_2thema
245 1 0 _aCardiovascular Outcomes Research
_h[electronic resource] :
_bA Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials /
_cedited by Kevin C. Maki, Don P. Wilson.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2024.
300 _aXVI, 438 p. 34 illus., 30 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aContemporary Cardiology,
_x2196-8977
505 0 _aChapter 1. History of Cardiovascular Epidemiology -- Chapter 2. Types of Cardiovascular Outcomes Studies -- Chapter 3. Basic Statistical Considerations for Cardiovascular Outcomes Studies -- Chapter 4. Evolving Concepts in Cardiovascular Outcomes Studies -- Chapter 5. Current Guidelines for Atherosclerotic Cardiovascular Disease Risk Reduction -- Chapter 6. Surrogate Markers of Cardiovascular Disease -- Chapter 7. Challenges in Developing Evidence-based Recommendations for Non-pharmacological Interventions for Atherosclerotic Cardiovascular Disease Risk Reduction -- Chapter 8. Overview of the Pharmaceutical Development Process for Agents to Influence Cardiovascular Health -- Chapter 9. Lipids and Cardiovascular Outcomes -- Chapter 10. Inflammation and Cardiovascular Outcomes -- Chapter 11. Hemostasis and Cardiovascular Outcomes -- Chapter 12. Cardiac Rhythms and Cardiovascular Outcomes -- Chapter 13. Blood Pressure and CardiovascularOutcomes -- Chapter 14. Diabetes, Obesity, Metabolic Syndrome and Cardiovascular Outcomes -- Chapter 15. Chronic Kidney Disease and Cardiovascular Outcomes. .
520 _aThis book provides clinicians with the information needed to effectively interpret the literature from observational and interventional cardiovascular outcomes studies. The book begins by providing a historical context of cardiovascular epidemiology, followed by chapters addressing key concepts in the study of cardiovascular disease such as the types of cardiovascular outcomes studies, basic and evolving design and statistical considerations, current guidelines for reducing atherosclerotic cardiovascular disease risk, surrogate markers of cardiovascular disease, challenges in developing evidence-based recommendations for non-pharmacological interventions, an overview of the pharmaceutical development process, and a detailed discussion of the clinical evidence supporting several factors and their relationships with atherosclerotic cardiovascular disease (lipids, inflammation, hemostasis, heart rhythm, blood pressure, diabetes, obesity, and chronic kidney disease). Cardiovascular Outcomes Research is a must-have resource for physicians and other clinicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention. .
650 0 _aCardiology.
_975410
650 0 _aEpidemiology.
_965983
650 0 _aMedicine
_xResearch.
_962598
650 0 _aBiology
_xResearch.
_965629
650 1 4 _aCardiology.
_975410
650 2 4 _aEpidemiology.
_965983
650 2 4 _aBiomedical Research.
_965633
700 1 _aMaki, Kevin C.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_977295
700 1 _aWilson, Don P.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_977296
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031549595
776 0 8 _iPrinted edition:
_z9783031549618
776 0 8 _iPrinted edition:
_z9783031549625
830 0 _aContemporary Cardiology,
_x2196-8977
_977297
856 4 0 _uhttps://doi.org/10.1007/978-3-031-54960-1
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c60067
_d60067